EUVIMEDOpdag EUVIMED
Video/Audio

Predicting Oxaliplatin-Induced Severe Neuropathy in Colorectal Cancer Patients with Diabetic Polyneuropathy

Yan Xu, Yanru Li, Jinfeng Rong, Ye Qiu

Journal of Visualized Experiments · 2026-10-30 · (236)

DOI: 10.3791/73732 ↗

At a glance

Video/Audio in Journal of Visualized Experiments, published online on 2026-10-30. Written by Yan Xu and 3 co-authors. Institution: Second People's Hospital of Yibin. Major MEDLINE topics: Oxaliplatin, Colorectal Neoplasms, Diabetic Neuropathies, Antineoplastic Agents.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Colorectal cancer (CRC) patients with comorbid diabetic peripheral neuropathy (DPN) face an increased risk of oxaliplatin-induced dose-limiting toxicity (DLT). This study aimed to develop a machine learning model to predict chemotherapy tolerance and investigate nonlinear feature associations within the predictive framework. We retrospectively analyzed 513 CRC patients with DPN. Five machine learning algorithms were developed and evaluated, and SHapley Additive exPlanations (SHAP) were used to explore feature associations. The XGBoost model demonstrated the highest discriminative performance in predicting DLT (AUC = 0.880), significantly outperforming logistic regression (p = 0.002). SHAP analysis showed that cumulative oxaliplatin dose, poor glycemic control (HbA1c > 8.0%), and systemic inflammation (NLR) were associated with increased model-predicted risk of DLT. Interaction analyses further identified nonlinear model-level associations between oxaliplatin exposure and metabolic and neurological features. The XGBoost model combined with SHAP explanations provides an exploratory framework for dynamic risk stratification during treatment. These findings represent associative predictive patterns and require prospective, external validation before clinical application.

Subjects

MeSH terms (MEDLINE)

OxaliplatinColorectal NeoplasmsDiabetic NeuropathiesAntineoplastic AgentsOrganoplatinum CompoundsHumansRetrospective StudiesBoosting Machine Learning AlgorithmsFemaleMaleMachine LearningMiddle Aged

Substances

OxaliplatinAntineoplastic AgentsOrganoplatinum Compounds

Authors and institutions

  • Second People's Hospital of Yibin.
  • Second People's Hospital of Yibin; LiYanru01234@163.com.

Cite

APA

Xu, Y., Li, Y., Rong, J., & Qiu, Y. (2026). Predicting Oxaliplatin-Induced Severe Neuropathy in Colorectal Cancer Patients with Diabetic Polyneuropathy. Journal of Visualized Experiments. https://doi.org/10.3791/73732

Vancouver

Xu Y, Li Y, Rong J, Qiu Y. Predicting Oxaliplatin-Induced Severe Neuropathy in Colorectal Cancer Patients with Diabetic Polyneuropathy. Journal of Visualized Experiments. 2026. doi:10.3791/73732

BibTeX
@article{Xu2026,
  author = {Xu, Yan and Li, Yanru and Rong, Jinfeng and Qiu, Ye},
  title = {Predicting Oxaliplatin-Induced Severe Neuropathy in Colorectal Cancer Patients with Diabetic Polyneuropathy},
  journal = {Journal of Visualized Experiments},
  year = {2026},
  number = {236},
  doi = {10.3791/73732}
}
Start for free →